Lichen or associated micro-organism compounds are active against human coronaviruses.
- Author:
- Desmarets L., Millot M., Chollet-Krugler M., Boustie J., Camuzet C., François N., Rouillé Y., Belouzard S., Tomasi S., Mambu L. & Séron K.
- Year:
- 2023
- Journal:
- Viruses
- Pages:
- 15(9): 1859 [15 p.]
- Url:
- https://doi.org/10.3390/v15091859
(1) Background: Since the emergence of SARS-CoV-2, responsible for the COVID-19 pandemic, efforts have been made to identify antiviral compounds against human coronaviruses. With the aim of increasing the diversity of molecule scaffolds, 42 natural compounds, of which 28 were isolated from lichens and 14 from their associated microorganisms (bacteria and fungi), were screened against human coronavirus HCoV-229E. (2) Methods: Antiviral assays were performed using HCoV-229E in Huh-7 and Huh-7/TMPRSS2 cells and SARS-CoV-2 in a Vero-81-derived clone with a GFP reporter probe. (3) Results: Four lichen compounds, including chloroatranol, emodin, perlatolic acid and vulpinic acid, displayed high activities against HCoV-229E (IC50 = 68.86, 59.25, 16.42 and 14.58 μM, respectively) and no toxicity at active concentrations. Kinetics studies were performed to determine their mode of action. The four compounds were active when added at the replication step. Due to their significant activity, they were further tested on SARS-CoV-2. Perlatolic acid was shown to be active against SARS-CoV-2. (4) Conclusions: Taken together, these results show that lichens are a source of interesting antiviral agents against human coronaviruses. Moreover, perlatolic acid might be further studied for its pan-coronavirus antiviral activity.
Keywords: antiviral; natural product; coronavirus; HCoV-229E; SARS-CoV-2; lichen compounds.
- Id:
- 35763
- Submitter:
- zpalice
- Post_time:
- Sunday, 03 September 2023 01:09